Another way drug companies are responding to the GLP-1 shortage is by bringing new therapeutic options to the market
[12] [22] Patients with fibromyalgia typically experience a constellation of symptoms beyond pain, including: Chronic widespread pain lasting at least three months, affecting multiple body regions Profound fatigue that is not relieved by rest Sleep disturbances , including non-restorative sleep and frequent waking Cognitive impairment , affecting concentration and memory Mood disorders , such as anxiety and depression Headaches , irritable bowel syndrome, and heightened sensitivity to temperature, light, and noise Diagnosis is primarily clinical, based on patient history and examination, as there are no specific laboratory tests or imaging studies that confirm fibromyalgia
Enhances your bodys natural defenses against illness and disease
Eso es lo que no mostraron en la mayora de los reportajes en los medios, a pesar de que es la primera frase del artculo
hdl:10447/463258
they do not establish biological outcomes or use guidance